Skip to main content
. 2020 Aug 30;12(9):962. doi: 10.3390/v12090962

Table 3.

Group characteristics and risk factors of HPV infection.

HPV+ HPV− p
Age (years) 45.1 ± 13.6 46.7 ± 12.9 0.582
Duration of immunotherapy (months) 102.0 ± 68.7 93.1 ± 85.7 0.495
BMI 25.01 ± 5.31 24.18 ± 4.97 0.418
Habitat 0.156
Town > 100 000 14 (15.6%) 29 (32.2%)
Town < 100 000 7 (7.8%) 10 (11.1%)
Village 5 (5.6%) 25 (27.8%)
Education 0.367
Primary 3 (3.3%) 3 (3.3%)
Secondary 5 (5.6%) 19 (21.1%)
Vocational 6 (6.7%) 20 (22.2%)
Higher 12 (13.3%) 22 (24.4%)
Age at sexual initiation (years) 20.08 ± 3.63 20.33 ± 4.56 0.763
Number of lifetime
sexual partners (0–6)
1 10 (11.1%) 41 (45.6%) 0.026
≥2 16 (17.8%) 23 (25.6%)
Oral contraception users 12 (13.3%) 21 (23.3%) 0.234
Sexual orientation 0.700
Heterosexual 24 (30%) 55 (68.75%)
Homosexual 0 0
Bisexual 0 1 (1.5%)
History of STDs 1 (1.2%) 1 (1.2%) 0.500
Smoking 2 (2.3%) 4 (4.5%) 0.820

HPV—human papillomavirus; HPV+—women positive for high-risk human papillomavirus; HPV−—women negative for high-risk human papillomavirus; BMI—body mass index; STDs—sexually transmitted diseases.